Price Action Don’t Lie: Could Natural Alternatives International, Inc. Change Direction After Today’s Significant Increase?

Price Action Don't Lie: Could Natural Alternatives International, Inc. Change Direction After Today's Significant Increase?

The stock of Natural Alternatives International, Inc. (NASDAQ:NAII) is a huge mover today! The stock increased 1.78% or $0.23 on September 30, hitting $13.14. About 145,013 shares traded hands or 183.59% up from the average. Natural Alternatives International, Inc. (NASDAQ:NAII) has risen 5.82% since February 26, 2016 and is uptrending. It has underperformed by 4.61% the S&P500.
The move comes after 8 months positive chart setup for the $88.67 million company. It was reported on Oct, 1 by Barchart.com. We have $28.78 PT which if reached, will make NASDAQ:NAII worth $105.52M more.

According to Zacks Investment Research, “NATURAL ALTERNATIVES INTL INC is engaged in the formulation and production of encapsulated vitamins and nutrients and provides for its clients assistance with foreign registration of products, graphic design, brochures, formulations and a host of other marketing related services.”

Insitutional Activity: The institutional sentiment decreased to 1.6 in Q2 2016. Its down 1.84, from 3.44 in 2016Q1. The ratio worsened, as 3 funds sold all Natural Alternatives International, Inc. shares owned while 12 reduced positions. 5 funds bought stakes while 19 increased positions. They now own 1.77 million shares or 41.66% less from 3.04 million shares in 2016Q1.
Art Advsr Ltd Liability Com accumulated 15,900 shares or 0.01% of the stock. Hightower Advsr Lc holds 41,344 shares or 0.01% of its portfolio. Nationwide Fund owns 10,000 shares or 0% of their US portfolio. Dimensional Fund Lp last reported 0% of its portfolio in the stock. The New York-based Tower Rech Lc (Trc) has invested 0% in Natural Alternatives International, Inc. (NASDAQ:NAII). Moreover, Walleye Trading Ltd Liability Co has 0% invested in Natural Alternatives International, Inc. (NASDAQ:NAII) for 4,100 shares. Jpmorgan Chase And owns 4,005 shares or 0% of their US portfolio. Acadian Asset Mngmt Ltd Llc reported 1,199 shares or 0% of all its holdings. Navellier Associates owns 36,156 shares or 0.06% of their US portfolio. Architects owns 200 shares or 0% of their US portfolio. Moreover, Federated Investors Inc Pa has 0% invested in Natural Alternatives International, Inc. (NASDAQ:NAII) for 285 shares. Manufacturers Life Insur The has 865 shares for 0% of their US portfolio. Bridgeway Management has invested 0.02% of its portfolio in Natural Alternatives International, Inc. (NASDAQ:NAII). Moreover, Morgan Stanley has 0% invested in Natural Alternatives International, Inc. (NASDAQ:NAII) for 1,585 shares. Barclays Public Ltd last reported 0% of its portfolio in the stock.

Insider Transactions: Since June 3, 2016, the stock had 0 insider buys, and 2 sales for $915,281 net activity. Another trade for 76,522 shares valued at $891,481 was made by Borg Edward on Friday, June 3. Another trade for 2,000 shares valued at $23,800 was sold by WELDON LEE G.

More notable recent Natural Alternatives International, Inc. (NASDAQ:NAII) news were published by: Prnewswire.com which released: “Natural Alternatives International, Inc. Announces Fiscal 2016 Q4 Results” on September 19, 2016, also Marketwatch.com with their article: “Natural Alternatives International Inc.” published on March 29, 2011, Prnewswire.com published: “Natural Alternatives International, Inc. Promotes President and Chief …” on October 01, 2015. More interesting news about Natural Alternatives International, Inc. (NASDAQ:NAII) were released by: Prnewswire.com and their article: “Natural Alternatives International, Inc. Announces Issuance of New U.S. Beta …” published on April 15, 2016 as well as Prnewswire.com‘s news article titled: “Natural Alternatives International, Inc. Announces Fiscal 2015 Results” with publication date: September 18, 2015.

NAII Company Profile

Natural Alternatives International, Inc., incorporated on October 26, 1989, is a formulator, maker and marketer of nutritional supplements. The Firm operates through three divisions: private-label contract manufacturing, patent and trademark licensing, and branded products. The private-label contract manufacturing segment provides manufacturing services to companies that market and distribute nutritional supplements and other healthcare products. The patent and trademark licensing segment includes direct raw material sales and royalty income from its license and supply agreements associated with the sale and use of beta-alanine under its CarnosSyn trade name. The branded products segment markets and distributes branded nutritional supplements and consists primarily of the products sold under its Pathway to Healing product line.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment